Pharma stock Eli Lilly is trading in a buy zone as institutional investors load up. The stock has rallied nearly 36% from recent lows.
Stock Spotlight
Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up.
Licensing
01:01 PM ET 06/12/2026
With the massive SpaceX (SPCX) debut hogging the headlines, some retail investors may have allowed more prosaic names to slip from their minds. Pharma stock Eli Lilly (LLY) is trading in a buy zone as institutional investors load up. The Indianapolis-based company is one of the biggest drugmakers in the world. It has a diversified suite of treatments, including its…
The maker of weight-loss drug Zepbound springs back into buy range.
Eli Lilly (NYSE:LLY) shares jumped on Thursday morning after securing expanded PBM coverage for its blockbuster obesity…
Bank of America's new price target has shares of Eli Lilly climbing 22% from here.
The company's stock has zoomed this year, driven by the explosive growth of the weight-loss drug market.
Eli Lilly entered Thursday well off its highs. A blowout quarter shows the market got this one wrong.
Leerink Partners sees shares of Eli Lilly adding another 19% from here.
